Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study-Reference-Cited by-同舟云学术

Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study

Published:2019-12 Issue:12 Volume:110 Page:3754-3760
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ishikawa Takeshi¹²^ORCID,Yasuda Tomoyo¹,Okayama Tetsuya¹,Dohi Osamu¹,Yoshida Naohisa¹,Kamada Kazuhiro¹,Uchiyama Kazuhiko¹,Takagi Tomohisa¹,Konishi Hirotaka³^ORCID,Shiozaki Atsushi³^ORCID,Fujiwara Hitoshi³,Konishi Hideyuki¹,Naito Yuji¹,Teramukai Satoshi⁴,Itoh Yoshito¹

Affiliation:

1. Department of Gastroenterology and Hepatology Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

2. Outpatient Oncology Unit University Hospital Kyoto Prefectural University of Medicine Kyoto Japan

3. Division of Digestive Surgery Department of Surgery Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

4. Department of Biostatistics Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14218

Reference23 articles.

1. The Global Burden of Cancer 2013

2. Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus

3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

4. Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

5. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial;The Lancet;2024-07

2. Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology;International Journal of Clinical Oncology;2024-04-05

3. Clinical utility of pegfilgrastim on day 3 of preoperative docetaxel, cisplatin and 5-fluorouracil chemotherapy in elderly patients with resectable esophageal cancer;2024-01-24

4. Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer;Cancer Medicine;2024-01

5. Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients;International Journal of Clinical Oncology;2023-12-08